completed

PIAAF Pharmacy was a Canadian multicentre study of atrial fibrillation (AF) screening in the community using a novel single-lead ECG device of participants aged 65 and older.

The study’s objective was to determine the prevalence of actionable atrial fibrillation defined as those with:
i) previously unrecognized AF and;
ii) those with AF but suboptimal anticoagulation therapy through pharmacy-led screening.

Primary outcome:

Prevalence of “actionable: AF in the community through pharmacy-led screening using a handheld ECG device.

Co-Principal Investigators of PIAAF Pharmacy, along with PHRI’s Jeff Healey were:

  • Lisa Dolovich, Department of Family Medicine at McMaster University
  • Roopinder Sandhu, University of Alberta
Study Type

Observational

Study Design

Cohort study

NO. of Countries

1

NO. of Sites

30

NO. of Participants

1137

Study Period

2014 - 2015

Sponsor

PHRI

Canadian Stroke Prevention Intervention Network (C-SPIN)

Back To Top